Cardiovascular Pharmacology

Citations 141-150 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response: Daniela Fraccarollo, Paolo Galuppo, Susanne Schraut, Susanne Kneitz, Nico van Rooijen, Georg Ertl, and Johann Bauersachs
Hypertension published February 25, 2008, doi:10.1161/HYPERTENSIONAHA.107.100941 [Abstract]

Scientific Contributions
Wine Polyphenols Improve Endothelial Function in Large Vessels of Female Spontaneously Hypertensive Rats: Rocío López-Sepúlveda, Rosario Jiménez, Miguel Romero, Maria José Zarzuelo, Manuel Sánchez, Manuel Gómez-Guzmán, Félix Vargas, Francisco O’Valle, Antonio Zarzuelo, Francisco Pérez-Vizcaíno, and Juan Duarte
Hypertension published February 7, 2008, doi:10.1161/HYPERTENSIONAHA.107.107672 [Abstract]

Scientific Contributions
Medroxyprogesterone Abrogates the Inhibitory Effects of Estradiol on Vascular Smooth Muscle Cells by Preventing Estradiol Metabolism: Raghvendra K. Dubey, Edwin K. Jackson, Delbert G. Gillespie, Lefteris C. Zacharia, Dorothea Wunder, Bruno Imthurn, and Marinella Rosselli
Hypertension published February 7, 2008, doi:10.1161/HYPERTENSIONAHA.107.106575 [Abstract]

Scientific Contributions
Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite: Andrew J. Webb, Nakul Patel, Stavros Loukogeorgakis, Mike Okorie, Zainab Aboud, Shivani Misra, Rahim Rashid, Philip Miall, John Deanfield, Nigel Benjamin, Raymond MacAllister, Adrian J. Hobbs, and Amrita Ahluwalia
Hypertension published February 4, 2008, doi:10.1161/HYPERTENSIONAHA.107.103523 [Abstract]

Original Articles
Low Concentrations of Sphingosylphosphorylcholine Enhance Pulmonary Artery Vasoreactivity: The Role of Protein Kinase C ${delta}$ and Ca²⁺ Entry: Vladimir A. Snetkov, Gavin D. Thomas, Bonnie Teague, Richard M. Leach, Yasin Shaifta, Greg A. Knock, Philip I. Aaronson, and Jeremy P.T. Ward
Hypertension 2008;51:239-245; published online before print as doi:10.1161/HYPERTENSIONAHA.107.104802 [Abstract] [Full text]

Original Articles
Ethnic and Genetic Determinants of Cardiovascular Response to the Selective ${alpha}$ ₂-Adrenoceptor Agonist Dexmedetomidine: Daniel Kurnik, Mordechai Muszkat, Gbenga G. Sofowora, Eitan A. Friedman, William D. Dupont, Mika Scheinin, Alastair J.J. Wood, and C. Michael Stein
Hypertension 2008;51:406-411; published online before print as doi:10.1161/HYPERTENSIONAHA.107.098939 [Abstract] [Full text]

Editorial Commentary
More NO-No More ROS Combined Selective Mineralocorticoid Receptor Blockade and Angiotensin-Converting Enzyme Inhibition for Vascular Protection: Johann Bauersachs and Daniela Fraccarollo
Hypertension published January 28, 2008, doi:10.1161/HYPERTENSIONAHA.107.106625 [Abstract]

Brief Reviews
Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways: Promising Offensives Against Vascular Injury: Ruba S. Deeb, Rita K. Upmacis, Brian D. Lamon, Steven S. Gross, and David P. Hajjar
Hypertension 2008;51:1-7; published online before print as doi:10.1161/HYPERTENSIONAHA.107.092866 [Full text]

Brief Reviews
Interpretation of Plasma Renin Concentration in Patients Receiving Aliskiren Therapy: Duncan J. Campbell
Hypertension 2008;51:15-18; published online before print as doi:10.1161/HYPERTENSIONAHA.107.101287 [Full text]

Editorial Commentaries
Blood Pressure Targets After High-Risk Myocardial Infarction: Is It Time to Update the Guidelines?: Scott J. Denardo, R. David Anderson, and Carl J. Pepine
Hypertension 2008;51:26-27; published online before print as doi:10.1161/HYPERTENSIONAHA.107.099291 [Full text]

Subspecialty Collections Home

Show Cardiovascular Pharmacology
collections from other journals.